XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue Recognition (Details) - Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]        
Revenue     $ 1,639,863  
Cost of revenue $ 266,445 $ 107,535 514,488 $ 356,932
Gross profit     $ 1,125,375  
Gross Profit %     68.63%  
Assets 3,079,586   $ 3,079,586  
Net profit (loss) (2,076,620) $ (2,030,223) (4,037,640) $ (3,700,470)
Global Stem Cells Group [Member]        
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]        
Revenue     1,610,363  
Cost of revenue     514,488  
Gross profit     $ 1,095,875  
Gross Profit %     68.05%  
Assets 1,168,726   $ 1,168,726  
Net profit (loss)     (104,647)  
Meso Numismatics [Member]        
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]        
Revenue      
Cost of revenue      
Gross profit      
Gross Profit %     0.00%  
Assets $ 1,910,860   $ 1,910,860  
Net profit (loss)     $ (3,932,993)